Schwartz Investment Counsel’s St Jude Medical STJ Stock Holding History

Schwartz Investment Counsel’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-535,000	Closed	-$41.7M	–	134
2016 Q2	$41.7M	Sell	535,000 -41,000	-7%	-$2.92M	3.02%	2
2016 Q1	$31.7M	Buy	576,000 +99,800	+21%	+$5.44M	2.38%	10
2015 Q4	$29.4M	Buy	476,200 +79,900	+20%	+$5.04M	2.23%	11
2015 Q3	$25M	Sell	396,300 -1,000	-0.3%	-$71.4K	1.94%	12
2015 Q2	$29M	Sell	397,300 -700	-0.2%	-$50.6K	1.98%	11
2015 Q1	$26M	Hold	398,000	–	–	1.73%	19
2014 Q4	$25.9M	Hold	398,000	–	–	1.72%	21
2014 Q3	$23.9M	Buy	398,000 +3,000	+0.8%	+$196K	1.72%	22
2014 Q2	$27.4M	Sell	395,000 -600	-0.2%	-$38.9K	1.94%	13
2014 Q1	$25.9M	Hold	395,600	–	–	1.92%	12
2013 Q4	$24.5M	Buy	395,600 +1,700	+0.4%	+$98.4K	1.84%	8
2013 Q3	$21.1M	Buy	393,900 +15,300	+4%	+$788K	1.8%	8
2013 Q2	$17.3M	Buy	+378,600	New	+$16.4M	1.72%	10

Other funds holding STJ

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Schwartz Investment Counsel's STJ Position: Q3 2016 in Review

Schwartz Investment Counsel sold out of St Jude Medical (STJ) in Q3 2016, closing a stake of 535,000 shares — an estimated $41.7M sold.

Schwartz Investment Counsel first reported a position in STJ in Q2 2013 and held it in 13 quarters. The position peaked at $41.7M in Q2 2016. 570 funds tracked by Wall St. Rank hold STJ as of Q3 2016.

Schwartz Investment Counsel reported no remaining St Jude Medical position as of Q3 2016 after selling out during the quarter.
Schwartz Investment Counsel sold 535,000 St Jude Medical shares in Q3 2016, an estimated $41.7M.
Schwartz Investment Counsel first reported a position in St Jude Medical in Q2 2013 and held it in 13 quarters.
Schwartz Investment Counsel's St Jude Medical position peaked at $41.7M in Q2 2016.
570 funds tracked by Wall St. Rank held St Jude Medical as of Q3 2016.

Based on Schwartz Investment Counsel's 13F filing for Q3 2016, filed 31 Oct 2016.